Rituximab‐induced vasculitis: A case report and review of the medical published work

ABSTRACT Rituximab is an anti‐CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side‐effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the Englis...

Full description

Saved in:
Bibliographic Details
Published inJournal of dermatology Vol. 36; no. 5; pp. 284 - 287
Main Authors KIM, Min Joo, KIM, Hyung Ok, KIM, Ho Yeon, PARK, Young Min
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.05.2009
Subjects
Adult
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents - adverse effects
Arthritis, Rheumatoid - drug therapy
Humans
Male
Rituximab
side effects
Skin - pathology
vasculitis
Vasculitis, Leukocytoclastic, Cutaneous - chemically induced
Vasculitis, Leukocytoclastic, Cutaneous - pathology
Online AccessGet full text

Cover

More Information
Summary:ABSTRACT Rituximab is an anti‐CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side‐effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38‐year‐old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0385-2407
1346-8138
DOI:10.1111/j.1346-8138.2009.00639.x